ArticleCancer cytopathology2017

Three-year risk of high-grade CIN for women aged 30 years or older who undergo baseline Pap cytology and HPV co-screening.

Ming Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.